UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001499 |
|---|---|
| Receipt number | R000001725 |
| Scientific Title | Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide for Patients with Urothelial Cancer (Phase I clinical study) |
| Date of disclosure of the study information | 2008/11/11 |
| Last modified on | 2009/11/17 18:19:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/11/11 20:23:44 | ||
| 2 | Update | 2009/11/17 18:19:50 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
